Chief Medical Officer

Mind Medicine’s LSD Dose Cuts Anxiety for 12 Weeks in Trial

MindMed to Participate in September Investor Conferences

Psychedelic Drugs Market Size to Surpass USD 10.11 Billion by 2032, Fueled by Breakthrough Therapies and Expanding Mental Health Applications – SNS Insider

Six psychedelic drug companies aiming to revolutionize mental health treatment

Senior Director, Product and Medical Affairs Counsel

MindMed is a clinical stage biopharmaceutical company focused on developing innovative treatments for brain health disorders. The Senior Director, Product and Medical Affairs Counsel will lead legal support for the company's Phase 3 product and provide counsel across various functions to ensure compliance with healthcare laws and regulations.

Sign up with Google

Sign in with Google